A false positive QuantiFERON Gold (QFT) test happens when the assay signals tuberculosis infection where none exists, and the causes range from lab handling errors and borderline-level results that fluctuate around the cutoff to biological interference from certain infections or immune conditions. In low-prevalence settings where most people tested are not actually infected, these false positives can far outnumber true positives, creating real anxiety and unnecessary treatment. The reasons are worth understanding in detail, because they change how you and your doctor should interpret a positive result.
How the Test Works, in Brief
The QFT draws blood into three tubes. One tube contains antigens specific to the bacterium that causes TB. A second tube serves as a positive control to make sure your immune cells can respond at all. A third “nil” tube contains no stimulant and measures background noise. After incubation, the lab measures how much interferon-gamma your white blood cells released in each tube. The result hinges on a subtraction: the response in the TB antigen tube minus the response in the nil tube. If that number exceeds 0.35 IU/mL, the test is called positive.1PubMed Central. Quantiferon-TB Gold in tube assay for the screening of tuberculosis before and during treatment with tumor necrosis factor alpha antagonists
That 0.35 cutoff is a single hard line, but biology does not produce binary results. A result of 0.36 and a result of 5.0 are both “positive,” yet they carry very different implications. Much of the false positive problem traces back to this mismatch between a sharp threshold and the messy reality of immune responses.
Borderline Results That Flip on Retesting
The single biggest contributor to false positives in everyday clinical practice is results that land just above the cutoff. A large study tracking people whose initial QFT fell between 0.35 and 0.99 IU/mL found that roughly 55% reverted to negative on follow-up testing, with many dropping well below the borderline range entirely.2PubMed Central. A borderline range for Quantiferon Gold In-Tube results A separate study in a low-prevalence setting confirmed that more than a third of people with borderline results tested convincingly negative on repeat, and none developed active TB within two years.3PubMed Central. The Impact of Borderline Quantiferon-TB Gold Plus Results for Latent Tuberculosis Screening under Routine Conditions in a Low-Endemicity Setting
This matters because a person living in a country where TB is uncommon, with no known exposure, whose test comes back at 0.4 or 0.5 IU/mL, has a very real chance that the result is noise rather than signal. Military health system data bears this out: among patients ultimately classified as false positive, the median TB-minus-nil value was 0.435 IU/mL, whereas true positives had a significantly higher median of 0.968 IU/mL.4PubMed Central. Predictors for False Positive Interferon Gamma Release Assays in the San Antonio Market of the Military Health System The lower the number above the cutoff, the less confident anyone should be that it reflects real TB infection.
Lab Handling and Preanalytical Errors
The QFT is sensitive to how the blood is handled between the draw and the lab. Several steps in the process can nudge a truly negative result across the 0.35 line.
Tube Shaking Intensity
After blood is drawn into the QFT tubes, the tubes need to be shaken to coat the blood with the antigens lining the tube walls. How vigorously that shaking is done turns out to matter. A study that directly compared gentle and vigorous shaking found that vigorous shaking roughly doubled the interferon-gamma response in the TB antigen tube and also raised the nil tube’s background signal.5PubMed Central. Impact of blood volume, tube shaking, and incubation time on reproducibility of QuantiFERON-TB gold in-tube assay Since the result depends on the difference between the antigen tube and the nil tube, inconsistent shaking between the tubes, or simply more vigorous shaking than the protocol intends, can distort the final number. Blood volume in each tube was also flagged as a source of variability in the same research.
Delays Before Incubation
The tubes are supposed to go into an incubator at body temperature promptly after the blood draw. When that step is delayed, accuracy drops. A study measuring the effect of waiting six or twelve hours before incubation found that about one in five previously positive results flipped to negative, meaning delay can push results in either direction depending on the underlying biology.6PubMed Central. Preanalytical delay reduces sensitivity of QuantiFERON-TB gold in-tube assay for detection of latent tuberculosis infection While this study focused on sensitivity loss, the broader point is that deviations from the protocol introduce unpredictable variability. For someone sitting right near the cutoff, that variability can determine whether the result reads positive or negative.
Defective Tube Lots
In a well-documented episode, a U.S. academic institution noticed its QFT positive rate suddenly jump from about 10% to 31%. An investigation traced the spike to a problem with a specific lot of TB antigen tubes. When samples were retested using tubes from a different lot, the inflated positive rate disappeared. The exact manufacturing defect was never identified.7PubMed Central. Investigation of false-positive results given by the QuantiFERON-TB Gold In-Tube assay This kind of event is rare, but it is a reminder that the test is a manufactured product subject to quality control failures, and a cluster of unexpected positives in a clinic should prompt investigation of the reagents before assuming everyone is infected.
Cross-Reactivity With Nontuberculous Mycobacteria
The QFT was designed to avoid the cross-reactivity problems that plague the older tuberculin skin test (TST). The antigens in the QFT tube, known as ESAT-6, CFP-10, and TB-7.7, are found in the TB bacterium but not in the BCG vaccine strain, which is why the QFT is preferred for people who have been vaccinated. However, these same antigens do exist in a handful of nontuberculous mycobacteria (NTM), environmental organisms that can colonize or infect people without being TB.
A study from Northern California looked at 88 patients with confirmed NTM infection and found the QFT’s specificity among them was about 76%, meaning roughly one in four gave a positive QFT result despite not having TB. When patients who also had risk factors for latent TB were removed from the analysis, specificity climbed to about 94%, but two patients still tested positive with NTM species known to share the QFT’s target antigens.8PubMed Central. Accuracy of QuantiFERON in active tuberculosis suspects with comorbidities and nontuberculous mycobacterial infection in Northern California This is a niche but real scenario. If you have a known NTM infection and your QFT comes back positive, the result should be interpreted cautiously.
The BCG vaccine itself, by contrast, is not a significant cause of false positive QFT results. The QFT antigens were specifically chosen to sidestep BCG. Research confirms that when people with a BCG vaccination history test positive on a QFT, latent TB infection is the more likely explanation than vaccine cross-reaction.9PubMed Central. Determining the Need for Additional Testing With Quantiferon TB Gold in Patients With Positive Tuberculin Skin Tests and a History of BCG Vaccination This is one of the test’s genuine strengths over the TST, where BCG-related false positives are a constant headache.
Autoimmune Conditions and Immune Interference
Certain immune conditions can generate interferon-gamma in ways that confuse the test. Rheumatoid arthritis (RA) is the best-studied example. Research has found that some RA patients produce elevated interferon-gamma even in the nil control tube, which is supposed to measure only background activity. In patients with false positive QFT results, the nil tube showed an average interferon-gamma level of 0.18 IU/mL, well above the near-zero values seen in healthy people.10PubMed Central. A mode of error: Immunoglobulin binding protein (a subset of anti-citrullinated proteins) can cause false positive tuberculosis test results in rheumatoid arthritis The suspected culprit is immunoglobulin binding proteins, a subset of anti-citrullinated protein antibodies common in RA, which can interfere with the ELISA that reads the test results.
This is particularly relevant because RA patients are often tested for TB before starting immunosuppressive treatments like TNF-alpha inhibitors. A false positive at that stage could delay treatment the patient genuinely needs. If you have RA or another condition associated with chronic immune activation and your QFT comes back positive at a low level, your clinician should weigh the nil tube value and consider retesting or using an alternative test.
Serial Testing and the Overdiagnosis Problem
Healthcare workers in countries where TB is uncommon often undergo QFT testing annually or on a regular schedule. This practice, intended to catch new infections early, has a mathematical problem: each round of testing carries a small chance of a false positive, and over multiple rounds those small chances accumulate. A modeling study estimated that serial testing of healthcare workers using the standard 0.35 cutoff resulted in about 25% of the entire tested population receiving at least one false positive over ten years, with nearly thirty false positives for every true infection diagnosed.11Scientific Reports. Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov model
That ratio is striking, and it explains why occupational health departments increasingly grapple with how to handle low-positive QFT results in workers with no TB exposure history. Many institutions have adopted a borderline zone, often 0.35 to 0.99 IU/mL, where retesting is recommended before acting on a positive. The evidence supports that approach: as noted above, more than half of initial results in that range revert to negative on follow-up.
False Positives in Children
Data on false positive QFT results in children is thinner than in adults, but the available evidence suggests it happens, particularly in children with chronic medical conditions. A case series from a Spanish hospital identified seven false positive QFT results out of 737 tests performed in children over a five-year period. Four of the seven children had underlying chronic conditions, one had an NTM lymph node infection, and the remaining two had indirect TB exposure histories that did not result in actual infection.12The Pediatric Infectious Disease Journal. False-positive Results of Quantiferon-Tb-Gold Assay in Children The false positive rate was low in absolute terms, but the authors emphasized that the pediatric literature on this question remains sparse. For children tested in low-prevalence settings, clinicians should apply the same skepticism to low-positive results as they would in adults.
How a Positive Result’s Value Changes With Context
One of the most underappreciated aspects of QFT interpretation is how dramatically the meaning of a positive result shifts depending on where you live and your exposure history. In a population-based study from a low-incidence country, the positive predictive value of the QFT for developing active TB was just 1.32%. The negative predictive value, by contrast, was 99.85%.13Thorax. Prognostic value of interferon-γ release assays, a population-based study from a TB low-incidence country In plain terms, in a low-TB setting, a positive QFT means there is roughly a 1 in 75 chance you will develop active TB, while a negative result is nearly ironclad reassurance that you will not.
That 1.32% figure surprises most people who receive a positive result. They tend to assume the test has “confirmed” infection, but in reality, the vast majority of positive results in low-prevalence countries do not lead to active disease, and a meaningful fraction are false positives to begin with. The test performs best as a rule-out tool: a negative result is extremely reliable. A positive result, especially a low positive, is a starting point for further evaluation rather than a diagnosis.
Does Switching Tests Help?
People who get an unexpected positive QFT sometimes ask whether the T-SPOT.TB, the other commercially available interferon-gamma release assay, would give a different answer. A systematic review and meta-analysis comparing the newer QFT-Plus with both the older QFT-GIT and the T-SPOT.TB found no statistically significant difference in specificity between the tests in very low-risk populations.14PubMed Central. Comparing the diagnostic performance of QuantiFERON-TB Gold Plus with QFT-GIT, T-SPOT.TB and TST: a systematic review and meta-analysis Concordance between QFT-Plus and T-SPOT was about 92%.15PubMed Central. Comparing QuantiFERON-TB Gold Plus with Other Tests To Diagnose Mycobacterium tuberculosis Infection Earlier head-to-head data had suggested QFT had slightly higher specificity than T-SPOT, though the difference was not statistically significant either.16European Respiratory Journal. Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection
In short, switching to T-SPOT after a positive QFT is not a reliable way to rule out a false positive, because the two tests share a similar biological basis and have comparable false positive rates. A more useful approach is to repeat the QFT itself, ideally with attention to ensuring proper blood handling, and to interpret the quantitative value in light of your risk profile.
What to Do With a Suspected False Positive
If you have received a positive QFT and suspect it may be false, there are several practical things to consider. First, ask for the actual interferon-gamma value, not just “positive” or “negative.” A result of 0.38 IU/mL carries far less weight than a result of 3.0 IU/mL. Second, look at the nil tube value. An elevated nil suggests possible immune interference, as seen in autoimmune conditions. Third, consider your actual risk. If you have never lived in or traveled to a TB-endemic area, have never been exposed to someone with active TB, and live in a low-incidence country, the prior probability of true infection is low, and a borderline positive is more likely to be noise.
Retesting is reasonable and widely recommended for borderline results. Many clinicians will also obtain a chest X-ray to look for signs of active or old TB. If the repeat QFT is negative and the chest X-ray is clear, the initial result is generally treated as a false positive and no treatment is pursued. For results that remain persistently positive at higher levels, treatment for latent TB infection may be recommended even when the risk of progression is modest, because the treatment regimens have shortened considerably in recent years and the side-effect profile is more manageable than it once was.
When Demographics and Risk Factors Do Not Predict False Positives
You might expect certain demographic patterns to emerge among people with false positive QFTs, but the available data does not bear that out cleanly. The military health system study mentioned earlier found no significant differences in demographics, risk factors, ordering location, or testing indication between people with true positive and false positive results. The only reliable distinguishing factor was the quantitative value itself: true positives had significantly higher TB-minus-nil values.4PubMed Central. Predictors for False Positive Interferon Gamma Release Assays in the San Antonio Market of the Military Health System This reinforces the importance of looking at the number, not just the binary call. A clinician cannot reliably guess who has a false positive based on age, sex, or exposure category alone. The quantitative result, combined with the clinical picture, is the best tool available.